Cydy sec filings
WebCYDY / CytoDyn Inc - SEC Filings, Annual Report, Proxy Statement EXTENDED Overview Owners Insiders Short Interest Filings Financials Dividends Earnings Forecast SEC … Web02/09/23. EFFECT. Notice of Effectiveness. 1. 02/03/23. POS AM. Post-effective amendment to a registration statement that is not immediately effective upon filing.
Cydy sec filings
Did you know?
WebDec 7, 2024 · SEC gov • December 07, 2024 ... Download. Exhibits 8-K EX-10.1. Advertisement. Advertisement. Related Filings from CYDY. 10-Q Quarterly report pursuant to Section 13 or 15(d) Jan 09, 2024. 8-K ... WebAug 15, 2024 · SEC gov • August 15, 2024. CYDY : 10-K Annual report pursuant to Section 13 and 15(d) Symbol. CYDY. ... Related Filings from CYDY. 8-K Current report filing. Mar 08, 2024.
WebCurrent report filing. 2. 04/25/22. D/A. Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4 (a) (5) under the Act. 6. 04/22/22. WebApr 10, 2024 · A high-level overview of CytoDyn Inc. (CYDY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. ... SEC Filings. Type: All.
WebAug 31, 2024 · SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2024 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1933 … WebSEC Filings GlobeNewswire CytoDyn to Hold Webcast to Provide a Company Update American City Business Journals Ousted CEO Pourhassan sues CytoDyn to cover his attorney's fees American City...
WebApr 10, 2024 · Cytodyn Inc. (CYDY) SEC Filing 10-Q Quarterly Report for the period ending Tuesday, February 28, 2024. ... Cytodyn Inc. (CYDY) 10-Q Quarterly Report Mon Apr 10 …
WebJan 10, 2024 · Ticker: CYDY CIK: 1175680 Form Type: 10-Q Quarterly Report Accession Number: 0001558370-22-000190 Submitted to the SEC: Mon Jan 10 2024 5:12:18 PM EST Accepted by the SEC: Mon Jan 10 2024 Period: Tuesday, November 30, 2024 Industry: Pharmaceutical Preparations External Resources: Stock Quote Social Media Bookmark … cpr cushion mask sold in bulkWebCytoDyn Inc. focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. The company was formerly known as RexRay Corporation. Formally known as: CytoDyn Inc. View SEC Filings from CYDY instead. Refresh Summary Table View recent insider … distance between incheon and seoulWebApr 10, 2024 · table of contents united statessecurities and exchange commissionwashington, dc 20549form quarterly report under section 13 or 15(d) of the securities exchange act of 1934for the cprc west pointWebJul 19, 2024 · Cytodyn Inc (CYDY) SEC Filings Nasdaq SEC Filings: CYDY Edit my quotes Cytodyn Inc (CYDY) 0 No Notifications Add to Watchlist Add to Portfolio Quotes … cprc section 4428WebApr 10, 2024 · Latest SEC filings for CytoDyn Inc. (CYDY). If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. cpr cy194 filterWebJan 9, 2024 · SEC.gov Filings & Forms Filings & Forms All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. Anyone can access and download this information for free. cprd14WebFind the latest CytoDyn Inc. (CYDY) stock quote, history, news and other vital information to help you with your stock trading and investing. cprd16